Ann: Positive preliminary results for PRENUMBRA Instant in stroke, page-9

I agree, personally I would rather the share price continue to behave irrationally and move below $10 in the shorter term, as long as they continue to deliver good news. Easily the best company on the ASX when considering the valuation relative to the existing fundamentals + the exciting pre-revenue pipeline, and each of these announcements just makes me want more and more shares in it. For those of us buying, I would say the relentless short campaign against this company is really a blessing in disguise. They are doing the heavy lifting getting this well below fair value for us to buy more of, and will sooner or later be forced to buy back c. 5% of the shares on issue (which is especially significant when you consider how illiquid the order book is due to how tightly held this is).